Single-dose Intravitreal Bevacizumab after Complete Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: an Effective Adjunctive Treatment

Patients with proliferative diabetic retinopathy (PDR) who are refractory to complete panretinal photocoagulation (PRP) have a high risk of severe vision loss. The aim of this study was to evaluate the effectiveness of single-dose intravitreal bevacizumab (IVB) after complete PRP in patients with re...

Descripción completa

Detalles Bibliográficos
Autores principales: DEHGHANI, Alireza, GHANBARI, Heshmatollah, MAHDIZADEH, Abdolsamad, POURAZIZI, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Hypothesis, Discovery & Innovation Ophthalmology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787026/
https://www.ncbi.nlm.nih.gov/pubmed/29392146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787026/
https://www.ncbi.nlm.nih.gov/pubmed/29392146

Ejemplares similares